clinical trial · NCT06389214
A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease
Dry Eye DiseaseReproxalap Ophthalmic Solution (0.25%)Vehicle Ophthalmic Solution
brief summary
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
started
Apr 9, 2024
primary completion
Jun 11, 2024
completion
Jun 11, 2024
last updated
Jun 5, 2025
detailed description
Dry eye chamber challenge trial.
official title
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol